Cargando…
Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin
BACKGROUND: Early detection of remnant gastric cancer (RGC) is required to reduce the risk of death, but long-term endoscopic surveillance is difficult after gastrectomy. In this study, data for the methylation status of 4 methylation genes (CDO1, HOPX, Reprimo, and E-cadherin) to predict the onset...
Autores principales: | Kojima, Keita, Minatani, Naoko, Ushiku, Hideki, Ishii, Satoru, Tanaka, Toshimichi, Yokoi, Keigo, Nishizawa, Nobuyuki, Ooizumi, Yosuke, Igarashi, Kazuharu, Hosoda, Kei, Moriya, Hiromitsu, Mieno, Hiroaki, Watanabe, Masahiko, Yamashita, Keishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497431/ https://www.ncbi.nlm.nih.gov/pubmed/31069006 http://dx.doi.org/10.18632/oncotarget.26814 |
Ejemplares similares
-
Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer
por: Kojima, Keita, et al.
Publicado: (2019) -
Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer
por: Kojima, Keita, et al.
Publicado: (2018) -
Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer
por: Nishizawa, Nobuyuki, et al.
Publicado: (2019) -
Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease
por: Igarashi, Kazuharu, et al.
Publicado: (2017) -
Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer
por: Harada, Hiroki, et al.
Publicado: (2019)